CANNABIS TESTING MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global cannabis testing market with an estimated market share of 40.3% in 2024, primarily due to legalization of both medical and recreational marijuana in major markets like the U.S. and Canada. Countries in this region have made significant investments in building a strong testing infrastructure to ensure product safety and quality.

The U.S. is the largest country market in North America due to increasing commercial cultivation and use of cannabis in states that have legalized it. While federal laws still prohibit marijuana, growing number of states permitting medical and recreational use continues can drive the need for compliance testing. Strict regulations require testing for dozens of parameters including potency, pesticides and heavy metals. This has created a booming testing industry to handle the large volumes and provide data needed for compliance and labeling purposes.

Latin America  is witnessing the fastest growth in the cannabis testing market, led predominantly by Brazil and Mexico. While medical cannabis is still illegal in Brazil, the government has shown positive signs of reforming laws and may legalize it in the future. This has local testing companies proactively enhancing their service portfolio to capture potential opportunities. Mexican Supreme Court's recent ruling has allowed recreational use, putting the nation on track to become a major hub in the recreational industry across Central and South America. Existing hemp producers are diversifying into other cannabis segments like CBD, presenting huge requirement for analytical testing capabilities in the region.